Literature DB >> 25337191

Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells.

Lei Wang1, Mei Zhang2, Dong-Xu Liu3.   

Abstract

PURPOSE: This study aims to explore the clinical characteristics of ATP binding cassette E1 (ABCE1) in oral squamous cell carcinomas (OSCC) and its roles in the proliferation, invasiveness, migration and apoptosis of the human oral squamous cell carcinoma cells CAL-27.
METHODS: The expression of ABCE1 and its target protein-RNase L, were first studied in tumor tissues of OSCC and adjacent non-tumor tissues. Moreover, CAL-27cells were transfected by ABCE1-specific shRNA, then MTT assay, the transwell and scratch assay were used to study cell proliferation and migration activity; the apoptosis rate and cell cycle distribution were tested by flow cytometry. Western blot and RT-PCR assay were adopted to measure their silencing efficacy.
RESULTS: ABCE1 expression is low in the adjacent non-tumor tissues while the expression is high in the oral cancer; the expression is reversely proportional to the differentiation degrees. The expression of RNaseL was in contrary to ABCE1. After transfected with ABCE1-siRNA, the proliferation, invasiveness and migration capabilities of cells decreased significantly whilst the apoptosis rate enhanced greatly (P < 0.01). Meanwhile, the expression of ABCE1 in CAL-27 cells was blocked (P < 0.01) while the expression of RNase L increased significantly (P < 0.01).
CONCLUSION: ABCE1 is closely connected with the pathogenesis and development of oral cancer, which acts through the cellular pathways of 2-5A/RNase L.

Entities:  

Keywords:  ABCE1; CAL-27 cells; RNase L; oral cancer; siRNA

Mesh:

Substances:

Year:  2014        PMID: 25337191      PMCID: PMC4203162     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways.

Authors:  M S Iordanov; J M Paranjape; A Zhou; J Wong; B R Williams; E F Meurs; R H Silverman; B E Magun
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Implications for RNase L in prostate cancer biology.

Authors:  Robert H Silverman
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

3.  Depleting ABCE1 expression induces apoptosis and inhibits the ability of proliferation and migration of human esophageal carcinoma cells.

Authors:  Bo Huang; Xiangnan Gong; Hongli Zhou; Fei Xiong; Siwang Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

4.  A plant orthologue of RNase L inhibitor (RLI) is induced in plants showing RNA interference.

Authors:  Antonio Sergio Kimus Braz; Jean Finnegan; Peter Waterhouse; Rogério Margis
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

5.  Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.

Authors:  C Bisbal; C Martinand; M Silhol; B Lebleu; T Salehzada
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

6.  Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.

Authors:  Ying Xiang; Zhengfu Wang; Junko Murakami; Sarah Plummer; Eric A Klein; John D Carpten; Jeffrey M Trent; William B Isaacs; Graham Casey; Robert H Silverman
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

7.  Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.

Authors:  Pawadee Lohavanichbutr; John Houck; David R Doody; Pei Wang; Eduardo Mendez; Neal Futran; Melissa P Upton; F Christopher Holsinger; Stephen M Schwartz; Chu Chen
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.

Authors:  Gabriella Aquino; Rocco Sabatino; Monica Cantile; Corrado Aversa; Franco Ionna; Gerardo Botti; Elvira La Mantia; Francesca Collina; Gabriella Malzone; Giuseppe Pannone; Nunzia Simona Losito; Renato Franco; Francesco Longo
Journal:  Biomed Res Int       Date:  2013-12-16       Impact factor: 3.411

9.  Killing effect of Ad5/F35-APE1 siRNA recombinant adenovirus in combination with hematoporphrphyrin derivative-mediated photodynamic therapy on human nonsmall cell lung cancer.

Authors:  Lei Xia; Wei Guan; Dong Wang; Yun-Song Zhang; Lin-Li Zeng; Zeng-Peng Li; Ge Wang; Zhen-Zhou Yang
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

10.  RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells.

Authors:  Tao Wang; Yanfang Mi; Linping Pian; Ping Gao; Hong Xu; Yuling Zheng; Xiaoyan Xuan
Journal:  Diagn Pathol       Date:  2013-06-24       Impact factor: 2.644

View more
  5 in total

1.  MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1.

Authors:  Dawei Zheng; Yan Dai; Song Wang; Xiaoyu Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Abce1 orchestrates M-phase entry and cytoskeleton architecture in mouse oocyte.

Authors:  Xiao-Fei Jiao; Chun-Jie Huang; Di Wu; Jia-Yu Zhang; Yu-Ting Long; Fan Chen; Xiang Li; Li-Jun Huo
Journal:  Oncotarget       Date:  2017-06-13

3.  Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1.

Authors:  Dong Wei; Lieying Yang; Bo Lv; Lijuan Chen
Journal:  Mol Vis       Date:  2017-07-03       Impact factor: 2.367

4.  Predicting chemosensitivity using drug perturbed gene dynamics.

Authors:  Joshua D Mannheimer; Ashok Prasad; Daniel L Gustafson
Journal:  BMC Bioinformatics       Date:  2021-01-07       Impact factor: 3.169

5.  Glucocorticoid counteracts cellular mechanoresponses by LINC01569-dependent glucocorticoid receptor-mediated mRNA decay.

Authors:  Huayu Zhu; Jun Li; Yize Li; Zhao Zheng; Hao Guan; Hongtao Wang; Ke Tao; Jiaqi Liu; Yunchuan Wang; Wanfu Zhang; Chao Li; Jie Li; Lintao Jia; Wendong Bai; Dahai Hu
Journal:  Sci Adv       Date:  2021-02-24       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.